Atmiben Alipitkumar Doshi Vs ITO (ITAT Ahmedabad)
In the realm of tax jurisprudence, the decision of the Income Tax Appellate Tribunal (ITAT) in Ahmedabad in the case of Atmiben Alipitkumar Doshi Vs ITO for the Assessment Year 2014-15 emerges as a noteworthy precedent. This case delves into the intricate scrutiny of Long Term Capital Gains (LTCG) on shares, particularly focusing on transactions deemed dubious by the tax authorities. This article meticulously unpacks the tribunal’s decision, offering insights into its implications for taxpayers and the legal framework governing LTCG on shares.
Background of the Case: Atmiben Alipitkumar Doshi (the assessee) appealed against the order passed by the CIT(A)-2, Ahmedabad, which confirmed the addition of Rs. 13,47,989 as LTCG from the sale of shares of Kappac Pharma Limited. The addition was made based on allegations of non-genuine transactions, despite the assessee’s contention that the transactions were supported by valid documents and met the conditions laid down for claiming exemption under Section 10(38) of the Income Tax Act, 1961.
Tribunal’s Deliberation and Ruling
- Examination of the Transaction’s Genuineness: The tribunal scrutinized the nature of the transactions involving Kappac Pharma Limited shares. Notably, the assessee’s purchase of shares was initially in cash and outside the regular stock exchange, raising questions about the transaction’s authenticity. The significant rise in the scrip’s value within 24 months further fueled suspicions.
- Assessment Order’s Foundation: Contrary to the assessee’s argument that the assessment order heavily relied on an investigation report from the Kolkata wing, the tribunal noted that the Assessing Officer (AO) had conducted an independent examination. This examination included the transaction’s mechanics and the disproportionate increase in the share price, suggesting the transaction’s ingenuity.
- Relevance of SEBI Investigation: The tribunal also considered the Securities and Exchange Board of India’s (SEBI) investigation into the scrip of Kappac Pharma Limited. While the assessee argued that mere suspension of trading by the BSE did not invalidate the genuineness of the transactions, the tribunal found that the assessee’s purchase at a higher price than the market rate was indicative of a bogus nature.
- Precedents and Judicial Interpretations: The tribunal distinguished the case from other precedents cited by the assessee, emphasizing that the factual matrix in Atmiben Alipitkumar Doshi’s case was distinct. It referenced the Hon’ble Delhi High Court’s decision in Udit Kalra, which dealt specifically with Kappac Pharma Limited scrip and found transactions in said scrip to be non-genuine.
Implications of the Tribunal’s Decision
The ITAT’s ruling in Atmiben Alipitkumar Doshi Vs ITO reinforces the principle that the onus is on the taxpayer to substantiate the genuineness of LTCG claims. Key takeaways include:
